EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Filter the list

Prikazano 1.801 - 2.000 od 4.917 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC	EU_BA Directive 2000/54/EC
cobalt dimolybdenum nickel octaoxide	268-169-5	68016-03-5	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt dinitrate	233-402-1	10141-05-6	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details
cobalt lithium nickel oxide	442-750-5	113066-89-0	Carc. 1A; Acute Tox. 2; STOT RE 1; Skin Sens. 1			Details
cobalt nickel dioxide	261-346-8	58591-45-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77332.	269-051-6	68186-89-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt nickel oxide	620-395-9	12737-30-3	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt oxide	215-154-6	1307-96-6	Acute Tox. 4; Skin Sens. 1			Details
cobalt sulfate	233-334-2	10124-43-3	Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details
cobalt sulfide	215-273-3	1317-42-6	Skin Sens. 1			Details
Coccidioides inunitis	-	-			F Fungi	Details
colchicine	200-598-5	64-86-8	Muta. 1B; Acute Tox. 2			Details
colecalciferol; cholecalciferol; Vitamin D3	200-673-2	67-97-0	Acute Tox. 2; STOT RE 1			Details
Coltivirus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated(n H2O,2 SUBSTANCE S171393	427-390-9	-	Skin Sens. 1			Details
condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily; amino-ethyl-piperazine and triethylenetetramine) INDULIN MQK-1M	413-770-1	-	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1			Details
constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside ALLYL SUCROSE	419-640-0	68784-14-5	Acute Tox. 4			Details
copper chloride; copper (I) chloride; cuprous chloride	231-842-9	7758-89-6	Acute Tox. 4			Details
copper dihydroxide; copper(II) hydroxide	243-815-9	20427-59-2	Acute Tox. 2; Acute Tox. 4; Eye Dam. 1			Details
copper flakes (coated with aliphatic acid)	-	-	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2			Details
copper sulphate	231-847-6	7758-98-7	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2			Details
copper sulphate pentahydrate	616-477-9	7758-99-8	Acute Tox. 4; Eye Dam. 1			Details
copper(II) carbonate-copper(II) hydroxide (1:1)	235-113-6	12069-69-1	Acute Tox. 4; Eye Irrit. 2			Details
copper(II) methanesulfonate KUPFER-II-METHANSULFONAT; KUPFERMETHANSULFONAT	405-400-2	54253-62-2	Acute Tox. 4; Eye Dam. 1			Details
coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool	204-810-7	126-90-9	Skin Sens. 1B			Details
Coronaviridae	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Corynebacterium diphtheriae	-	-			B Bacteria and similar species	Details
Corynebacterium minutissimum	-	-			B Bacteria and similar species	Details
Corynebacterium pseudotuberculosis	-	68583-16-4			B Bacteria and similar species	Details
Corynebacterium spp.	-	-			B Bacteria and similar species	Details
coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin	201-378-1	81-82-3	STOT RE 2			Details
coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]coumarin	204-195-5	117-52-2	Acute Tox. 3; STOT RE 1			Details
coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate	200-285-3	56-72-4	Acute Tox. 2; Acute Tox. 4			Details
coumatetralyl; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin	227-424-0	5836-29-3	Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1			Details
coumithoate (ISO); O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate	-	572-48-5	Acute Tox. 3			Details
Cowpox virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Coxiella burnetii	-	-			B Bacteria and similar species	Details
Coxsackie viruses	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Creosote [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.	232-287-5	8001-58-9	Carc. 1B			Details
Creosote oil [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392°F to 617°F).] A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200°C to 325°C (392°F to 617°F).	263-047-8	61789-28-4	Carc. 1B			Details
Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.	292-606-9	90640-85-0	Carc. 1B			Details
Creosote oil, acenaphthene fraction; Wash Oil [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464°F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240°C to 280°C (464°F to 536°F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.	292-605-3	90640-84-9	Carc. 1B			Details
Creosote oil, high-boiling distillate; Wash Oil [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41°F).] The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).	274-565-9	70321-79-8	Carc. 1B			Details
Creosote oil, low-boiling distillate; Wash Oil [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).] The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).	274-566-4	70321-80-1	Carc. 1B			Details
Creutzfeldt-Jakob disease	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Crimean-Congo haemorrhagic fever	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine	208-622-6	535-89-7	Acute Tox. 2			Details
crotonaldehyde; 2-butenal	224-030-0	4170-30-3	Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate	231-720-5	7700-17-6	Acute Tox. 3			Details
crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate	206-083-1	299-86-5	Acute Tox. 4			Details
Cryptococcus neoformans var. gattii	-	-			F Fungi	Details
Cryptococcus neoformans var. neofonnans	-	-			F Fungi	Details
Cryptosporidium parvum	-	-			P Parasites	Details
Cryptosporidium spp.	-	-			P Parasites	Details
cumene	202-704-5	98-82-8	Flam. Liq. 3; Carc. 1B; Asp. Tox. 1; STOT SE 3			Details
cyanamide; carbanonitril	206-992-3	420-04-2	Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1			Details
cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile	244-544-9	21725-46-2	Acute Tox. 4			Details
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate	620-377-0	13067-93-1	Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2			Details
cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate	220-130-3	2636-26-2	Acute Tox. 4			Details
cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate	223-099-4	3734-95-0	Acute Tox. 2; Acute Tox. 3			Details
cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid CSDCA	419-150-7	113136-77-9	Acute Tox. 4			Details
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione	427-230-8	5571-36-8	Repr. 1B; STOT RE 2			Details
cyclohexadeca-1,9-diene	431-730-1	4277-06-9	Skin Irrit. 2; Skin Sens. 1			Details
cyclohexane	203-806-2	110-82-7	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3			Details
cyclohexane-1,2-dicarboxylic anhydride	201-604-9	85-42-7	Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1	RSP Respiratory sensitising properties (Article 57(f)) - human health)		Details
cyclohexanol	203-630-6	108-93-0	Acute Tox. 4; STOT SE 3; Skin Irrit. 2			Details
cyclohexanone	203-631-1	108-94-1	Flam. Liq. 3; Acute Tox. 4			Details
cyclohexanone, peroxide;cyclohexanone, peroxide [≤ 91 % solution]	235-527-7	12262-58-7	Org. Perox. A; Skin Corr. 1B; Acute Tox. 4			Details
cyclohexanone, peroxide;cyclohexanone, peroxide [≤ 91 % solution]	235-527-7	12262-58-7	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B			Details
cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione	200-636-0	66-81-9	Muta. 2; Repr. 1B; Acute Tox. 2			Details
cyclohexyl acrylate	221-319-3	3066-71-5	STOT SE 3; Skin Irrit. 2			Details
cyclohexylamine	203-629-0	108-91-8	Flam. Liq. 3; Repr. 2; Acute Tox. 4; Skin Corr. 1B			Details
cyclohexyldimethoxymethylsilane CHMMS; CHMS; DYNASYLAN 9407; Z-6187	402-140-1	17865-32-6	Skin Irrit. 2			Details
cyclohexylidene hydroperoxide;cyclohexylidene hydroperoxide [≤ 91 % solution]	220-279-4	2699-11-8	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B			Details
cyclohexylidene hydroperoxide;cyclohexylidene hydroperoxide [≤ 91 % solution]	220-279-4	2699-11-8	Org. Perox. A; Skin Corr. 1B; Acute Tox. 4			Details
cyclooct-4-en-1-yl methyl carbonate VIOLIFF	401-620-8	87731-18-8	Skin Sens. 1			Details
cyclopentane	206-016-6	287-92-3	Flam. Liq. 2			Details
cyclopentane-1,2,3,4-tetracarboxylic dianhydride	227-964-7	6053-68-5	Eye Irrit. 2; STOT SE 3			Details
cyclopentanone	204-435-9	120-92-3	Flam. Liq. 3; Eye Irrit. 2; Skin Irrit. 2			Details
cyclopentyl 2-phenylethyl ether	428-340-9	238088-70-5	Skin Irrit. 2			Details
cyclopentyl chloroformate CHLOROFORMIATE DE CYCLOPENTYLE; CYCLOPENTYLCHLORFORMIAT	411-460-0	50715-28-1	Flam. Liq. 3; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1			Details
cyclopropane	200-847-8	75-19-4	Flam. Gas 1; Press. Gas			Details
Cyclospora cayetanensis	-	-			P Parasites	Details
cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one	405-230-9	101205-02-1	Repr. 2			Details
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate	642-974-5	400882-07-7	Carc. 2; Skin Sens. 1A			Details
cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	269-855-7	68359-37-5	Lact.; Acute Tox. 2; STOT SE 1			Details
cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide	236-049-1	13121-70-5	Acute Tox. 4			Details
cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide	261-043-0	57966-95-7	Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1			Details
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60;cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	257-842-9	52315-07-8	Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Skin Sens. 1			Details
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60;cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	257-842-9	52315-07-8	Acute Tox. 4; STOT SE 3; STOT RE 2			Details
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol	619-020-1	94361-06-5	Repr. 1B; Acute Tox. 3; STOT RE 2			Details
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine	601-785-8	121552-61-2	Skin Sens. 1			Details
cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide	274-050-9	69581-33-5	Acute Tox. 3; Acute Tox. 4			Details
Cytomegalovirus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) DEM	408-120-9	65197-96-8	Acute Tox. 4; Eye Dam. 1			Details
d-carvone; (5S)-2-methyl-5- (prop-1-en-2-yl)cyclohex-2-en- 1-one	218-827-2	2244-16-8	Skin Sens. 1			Details
D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate	432-960-5	124655-09-0	Acute Tox. 4			Details
dalapon-sodium; sodium 2,2-dichloropropionate	204-828-5	127-20-8	Skin Irrit. 2; Eye Dam. 1			Details
dalapon; 2,2-dichloropropionic acid	200-923-0	75-99-0	Skin Irrit. 2; Eye Dam. 1			Details
daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid	216-485-9	1596-84-5	Carc. 2			Details
dapsone; 4,4'-diamino diphenyl sulfone	201-248-4	80-08-0	Acute Tox. 4			Details
dazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thione	208-576-7	533-74-4	Acute Tox. 4; Eye Irrit. 2			Details
DDT (ISO); clofenotane (INN); dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane	200-024-3	50-29-3	Carc. 2; Acute Tox. 3; STOT RE 1			Details
Decamethylcyclopentasiloxane; D5	208-764-9	541-02-6		PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
decanoic acid	206-376-4	334-48-5	Skin Irrit. 2; Eye Irrit. 2			Details
decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate	-	1563-67-3	Acute Tox. 3			Details
deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate	258-256-6	52918-63-5	Acute Tox. 3			Details
demephion-O (ISO); O, O-dimethyl O-2-methylthioethyl phosphorothioate	211-666-9	682-80-4	Acute Tox. 2; Acute Tox. 3			Details
demephion-S (ISO); O, O-dimethyl S-2-methylthioethyl phosphorothioate	219-971-9	2587-90-8	Acute Tox. 2; Acute Tox. 3			Details
demeton	620-378-6	8065-48-3	Acute Tox. 1; Acute Tox. 2			Details
demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate	206-053-8	298-03-3	Acute Tox. 1; Acute Tox. 2			Details
demeton-O-methyl (ISO); O-2-ethylthioethyl O,O-dimethyl phosphorothioate	212-758-1	867-27-6	Acute Tox. 3			Details
demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate	204-801-8	126-75-0	Acute Tox. 1; Acute Tox. 2			Details
demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate	213-052-6	919-86-8	Acute Tox. 3			Details
demeton-S-methylsulphon(ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate	241-109-5	17040-19-6	Acute Tox. 3; Acute Tox. 4			Details
Dengue virus type 1-4	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate	237-198-5	13684-56-5	Repr. 2			Details
desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine	213-800-1	1014-69-3	Acute Tox. 4			Details
di(benzothiazol-2-yl) disulphide	204-424-9	120-78-5	Skin Sens. 1			Details
di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates DIRECT BLUE 199	416-180-2	12222-04-7	Acute Tox. 4; STOT RE 2			Details
Di-, tri- and tetrachlorotetradecane	950-299-5	-		PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate	218-961-1	2303-16-4	Carc. 2; Acute Tox. 4			Details
di-L-para-menthene PINOLENE	417-870-6	83648-84-4	Skin Irrit. 2; Skin Sens. 1			Details
di-L-para-menthene	686-814-2	34363-01-4	Skin Irrit. 2; Skin Sens. 1			Details
di-methylamine;di-methylamine ... %	204-697-4	124-40-3	Flam. Gas 1; Press. Gas; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
di-methylamine;di-methylamine ... %	204-697-4	124-40-3	Flam. Liq. 1; Acute Tox. 4; Skin Corr. 1B			Details
di-n-butyl ether; dibutyl ether	205-575-3	142-96-1	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2			Details
di-n-butylamine	203-921-8	111-92-2	Flam. Liq. 3; Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B; Eye Dam. 1			Details
di-n-octylaluminium iodide DNOAI	408-190-0	7585-14-0	Pyr. Liq. 1; Skin Corr. 1B			Details
di-n-pentyl phthalate	205-017-9	131-18-0	Repr. 1B	R Toxic for reproduction (article 57c)		Details
di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate CM 26-137	406-052-4	125078-60-6	Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
di-tert-butyl peroxide	203-733-6	110-05-4	Org. Perox. E; Flam. Liq. 2; Muta. 2			Details
dialifos (ISO); 2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate	233-689-3	10311-84-9	Acute Tox. 2; Acute Tox. 3			Details
diallyl phthalate	205-016-3	131-17-9	Acute Tox. 4			Details
dialuminium nickel tetraoxide	234-454-8	12004-35-2	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
diaminotoluene [technical product — reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]	-	-	Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1			Details
diamminediisocyanatozinc GENIPLEX A	401-610-3	122012-52-6	Acute Tox. 4; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1			Details
diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate	422-670-7	150202-11-2	Repr. 2; Acute Tox. 3; STOT RE 2			Details
diammonium hexachloroplatinate	240-973-0	16919-58-7	Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1			Details
diammonium nickel bis(sulfate)	239-793-5	15699-18-0	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1			Details
diammonium nickel hexacyanoferrate	-	74195-78-1	Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1			Details
diammonium peroxodisulphate; ammonium persulphate	231-786-5	7727-54-0	Ox. Sol. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1			Details
diammonium tetrachloroplatinate	237-499-1	13820-41-2	Acute Tox. 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1			Details
diarsenic pentaoxide; arsenic pentoxide; arsenic oxide	215-116-9	1303-28-2	Carc. 1A; Acute Tox. 3	C Carcinogenic (article 57a)		Details
diarsenic trioxide; arsenic trioxide	215-481-4	1327-53-3	Carc. 1A; Acute Tox. 2; Skin Corr. 1B	C Carcinogenic (article 57a)		Details
diazinon (ISO); O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate	206-373-8	333-41-5	Acute Tox. 4			Details
diazomethane	206-382-7	334-88-3	Carc. 1B			Details
dibenz[a,h]anthracene	200-181-8	53-70-3	Carc. 1B			Details
dibenzo[b,def]chrysene; dibenzo[a,h]pyrene	205-878-0	189-64-0	Carc. 1B; Muta. 2			Details
dibenzo[def,p]chrysene; dibenzo[a,l]pyrene	205-886-4	191-30-0	Carc. 1B; Muta. 2			Details
dibenzoyl peroxide; benzoyl peroxide	202-327-6	94-36-0	Org. Perox. B; Eye Irrit. 2; Skin Sens. 1			Details
dibenzylphenylsulfonium hexafluoroantimonate ZK RT 1507	417-760-8	134164-24-2	STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1			Details
diboron trioxide	215-125-8	1303-86-2	Repr. 1B	R Toxic for reproduction (article 57c)		Details
dibromomethane	200-824-2	74-95-3	Acute Tox. 4			Details
dibutyl phthalate; DBP	201-557-4	84-74-2	Repr. 1B	R Toxic for reproduction (article 57c) END Endocrine disrupting properties (Article 57(f) - human health) ENDE Endocrine disrupting properties (Article 57(f) - environment)		Details
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate AMINODARONE OXALATE; SR33580A	448-700-9	500791-70-8	STOT RE 2; Eye Dam. 1; Skin Sens. 1			Details
dibutylbis(pentane-2,4-dionato-O,O')tin	245-152-0	22673-19-4	Repr. 1B; STOT RE 1	R Toxic for reproduction (article 57c)		Details
dibutyltin bis (2-ethylhexanoate)	220-481-2	2781-10-4	Muta. 2; Repr. 1B; STOT RE 1			Details
dibutyltin di(acetate)	213-928-8	1067-33-0	Muta. 2; Repr. 1B; STOT RE 1			Details
dibutyltin dichloride; (DBTC)	211-670-0	683-18-1	Muta. 2; Repr. 1B; Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Corr. 1B	R Toxic for reproduction (article 57c)		Details
dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)] stannane	201-039-8	77-58-7	Muta. 2; Repr. 1B; STOT RE 1			Details
dibutyltin hydrogen borate DBB	401-040-5	75113-37-0	Repr. 1B; Muta. 2; STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1			Details
dibutyltin maleate	201-077-5	78-04-6	Muta. 2; Repr. 1B; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Skin Corr. 1; Eye Dam. 1			Details
dibutyltin oxide	212-449-1	818-08-6	Muta. 2; Repr. 1B; Acute Tox. 3; STOT RE 1; Skin Irrit. 2; Eye Dam. 1			Details
dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid	217-635-6	1918-00-9	Acute Tox. 4; Eye Dam. 1			Details
dichlobenil (ISO); 2,6-dichlorobenzonitrile	214-787-5	1194-65-6	Acute Tox. 4			Details
dichlofenthion (ISO); O—2,4-dichlorophenyl O,O-diethyl phosphorothioate	202-564-5	97-17-6	Acute Tox. 4			Details
dichlofluanid (ISO); N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide	214-118-7	1085-98-9	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1			Details
dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone	204-210-5	117-80-6	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2			Details
dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane SILAN DCS	407-180-3	770722-36-6	Skin Corr. 1A			Details
dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid	220-487-5	2782-57-2	Ox. Sol. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3			Details
dichloroacetic acid	201-207-0	79-43-6	Skin Corr. 1A			Details
dichloroacetyl chloride	201-199-9	79-36-7	Skin Corr. 1A			Details
dichloroacetylene	620-404-6	7572-29-4	Unst. Expl.; Carc. 2; STOT RE 2			Details
dichlorodioctyl stannane	222-583-2	3542-36-7	Repr. 1B; Acute Tox. 2; STOT RE 1			Details
dichloromethane; methylene chloride	200-838-9	75-09-2	Carc. 2			Details
dichlorophen (ISO)	202-567-1	97-23-4	Acute Tox. 4; Eye Irrit. 2			Details
dichlorprop (ISO); 2-(2,4-dichlorophenoxy)propionic acid	204-390-5	120-36-5	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid D-2,4-DP; DICHLORPROP-P; DUPLOSAN DP-ACID	403-980-1	15165-67-0	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1			Details
dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate	200-547-7	62-73-7	Acute Tox. 2; Acute Tox. 3; Skin Sens. 1			Details
Dichromic acid	236-881-5	13530-68-2		C Carcinogenic (article 57a)		Details
dichromium tris(chromate); chromium III chromate; chromic chromate	246-356-2	24613-89-6	Ox. Sol. 1; Carc. 1B; Skin Corr. 1A; Skin Sens. 1	C Carcinogenic (article 57a)		Details
diclobutrazole (ISO);(R, R)-(±)-β-[(2,4-dichlorop henyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2- (1H—1,2,4-triazol-1yl)pentan-3-ol	620-436-0	75736-33-3	Eye Irrit. 2			Details
diclofop-methyl (ISO)methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate	257-141-8	51338-27-3	Acute Tox. 4; Skin Sens. 1			Details
dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol	204-082-0	115-32-2	Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1			Details
dicopper chloride trihydroxide	215-572-9	1332-65-6	Acute Tox. 4; Acute Tox. 3			Details
dicopper oxide; copper (I) oxide	215-270-7	1317-39-1	Acute Tox. 4; Eye Dam. 1			Details
dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)	200-632-9	66-76-2	STOT RE 1; Acute Tox. 4			Details
dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate	205-494-3	141-66-2	Acute Tox. 2; Acute Tox. 3			Details
dicyclohexyl phthalate	201-545-9	84-61-7	Repr. 1B; Skin Sens. 1	R Toxic for reproduction (article 57c) END Endocrine disrupting properties (Article 57(f) - human health)		Details
dicyclohexylamine	202-980-7	101-83-7	Acute Tox. 4; Skin Corr. 1B			Details
dicyclohexylammonium nitrite	221-515-9	3129-91-7	Acute Tox. 4			Details
dicyclohexylcarbodiimide	208-704-1	538-75-0	Acute Tox. 3; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1			Details
dicyclopentyldimethoxysilane DCPMS; DYNASYLAN 9415; EURENOR 5023; SAN-30; WACKER SILAN CP2-DIMETHOXY; Z-6228	404-370-8	126990-35-0	Skin Irrit. 2; Eye Dam. 1			Details
didecyldimethylammonium chloride	230-525-2	7173-51-5	Acute Tox. 4; Skin Corr. 1B			Details
dieldrin (ISO)	200-484-5	60-57-1	Carc. 2; Acute Tox. 1; Acute Tox. 3; STOT RE 1			Details
diethanolamine perfluorooctane sulfonate	274-460-8	70225-14-8	Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.			Details
diethanolamine salt of 4-CPA	258-526-3	53404-23-2	Acute Tox. 4			Details
diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate SIFOSIL; SIFOSIL KONZENTRAT G 96-00 FEST	401-770-4	148324-78-1	Skin Corr. 1B; Acute Tox. 4			Details
diethyl ether; ether	200-467-2	60-29-7	Flam. Liq. 1; Acute Tox. 4; STOT SE 3			Details
diethyl sulphate	200-589-6	64-67-5	Carc. 1B; Muta. 1B; Acute Tox. 4; Skin Corr. 1B	C Carcinogenic (article 57a) M Mutagen (article 57b)		Details

Prikazano 1.801 - 2.000 od 4.917 rezultata.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.

Footer Nav Items